Invitrometrix careers

Discovery-Q. Demonstration devices to enable in-house testing by customers. Discovery-Q is on track for customer availability in January 2019. The devices will be placed in collaborator and customer research labs in the pharmaceutical industry, life science industry and academic labs. The users of these devices will be our “customer design team,” giving us valuable feedback for the first-generation commercial device. With these devices, we will expand relationships with key opinion leaders and obtain our first purchase orders for the commercial device release.

Invitro-Q. First commercial devices targeted at the research market, focused on disease modeling and drug discovery. Invitro-Q is planned for availability in Q1 2020. The device will have a consumable component. The device and accompanying analytical software will permit real time culture monitoring with continuous data collection. Invitro-Q will fit inside a standard cell culture incubator.